Navigation Links
FDA Says, 'Wait' To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy
Date:5/12/2008

DUBLIN, Ohio, May 12 /PRNewswire/ -- On May 30, 2008, CareToLive will take to the streets with coast-to-coast protests in Chicago, New York, Philadelphia, Cleveland, Madison, Atlanta, Seattle, Dearborn, and Tampa. Joining us will be the Cancer Cure Coalition, the Abigail Alliance, A Right To Live, and the Sarcoma Foundation of America. We are asking all patient advocates to come out and attend a protest.

1 in 6 men get prostate cancer. 75 American men die from it every day. The FDA has not approved a treatment for stage IV prostate cancer in over 43 years.

CareToLive, a not for profit corporation, seeks transparency and accountability from the FDA, as to why they disregarded the advice of their hand selected Congressionally mandated Advisory Panel of experts, who voted Provenge overwhelmingly safe and effective. Without cause or explanation, in an unprecedented action, the FDA denied licensure. We are seeking immediate access to Provenge for all men with end stage prostate cancer.

Over a year has passed, and 27,000 American men have died without hope, since the FDA denied the licensure of Provenge, an immunotherapy the FDA panel voted 17-0 safe and overwhelmingly voted effective. This is a noninvasive, non-toxic, immune building treatment, which works by employing your own body's healthy cells to fight the cancer.

Men like Eduardo Garcia, who have had the 3 treatments, have gone from being incapacitated, to living healthy, productive lives, for as long as seven years and counting. Dendreon, the company that perfected this treatment, also has similar treatments for breast, ovarian, colon, lung, kidney, and cervical cancers, in their sights.

The dysfunctional FDA's reason for delay has never been explained, as it was not science based, since survival and safety have been clearly demonstrated.

CareToLive filed a Citizens Petition for the FDA to reconsider the wrongful denial, (the only recourse the FDA allows), on July 26, 2007. The FDA has failed to follow Federal regulation and to this day they have not properly responded to our Petition, which seeks immediate access to Provenge for these desperate men. The FDA also refuses to respond to the CareToLive Freedom of Information Act request, which they know would prove that a few FDA insiders, who cared more about serving their own interests, rather than the best interest of the patients, purposely sabotaged Provenge.

"In memory of our members who have recently passed away, never having been given the chance Provenge recipient Eduardo Garcia had, we will continue to fight on, every day, in every way we can. Please come out and join us," CareToLive spokesperson, Mike Kearney, said.

LOCATIONS:

Seattle, Washington -- 1 PM PDT

Westlake Park (Downtown) - 400 Pine St

Coordinator - Jason Burdine jnaburdine@comcast.net

Co-Coordinator - Monica Sagen - bikeriding2@yahoo.com

Chicago, Illinois -- 3 PM CDT

ASCO / McCormick Place - 2301 S. Lake Shore Drive

Coordinator - Sean Morgan - morgan2174@yahoo.com

Co-coordinator - Arnie Mass - Ammass14@aol.com

Cleveland, Ohio -- 4 PM EDT

Public Square outside terminal tower - downtown

Coordinator - Kerry Donahue - bedonwahoo@aol.com

Co-coordinator - Mike Bauman - jmb15mjb4@gmail.com

Dearborn, Michigan -- 3 PM EDT

Rep. John Dingell's Office - 19855 West Outer Drive

Coordinator - Gregg Burch - ctl-dearborn-rally@live.com

Madison, Wisconsin -- 4 PM CDT

Wisconsin State Capitol Building - 2 East Main Street

Coordinator - Melody Davis - MDavis@caretolive.com

Tampa, Florida -- 3 PM EDT

H. Lee Moffitt Cancer Center & Research Institute

University of South Florida

12902 Magnolia Drive

Coordinator - Terry Rush - tdrush2505@aol.com

Philadelphia, Pennsylvania -- 2 PM EDT

2 PM Assemble and pass out flyers at 12th & Market Street for march to FDA

at 4 PM - 200 Chestnut Street U.S. Customhouse Building

Coordinator - Mike Kearney - publicrelations@caretolive.com

Co-coordinator- Rory Kearney - rk@caretolive.com

New York, NY -- 9 AM EDT

Memorial Sloan-Kettering Cancer Center - 1275 York Avenue

Co-Coordinators - Leslie Mulkey - lhrmulkey@aol.com

Kevin Ward - kward3@nyc.rr.com

Atlanta, Georgia -- 3 PM EDT

Atlanta FDA Regional Office - 60 Eighth St. N.E.

Coordinator- Bob Madden - rjmcanoe@aol.com

For more information go to http://www.CareToLive.com

Mike Kearney, cell, +1-908-670-7951; office, +1-856-770-8540,

publicrelations@caretolive.com


'/>"/>
SOURCE CareToLive
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. EPI Says, California Health Care Reform Bill is Misguided
2. Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
3. Long-awaited international ethical guidelines for biobank researchers
4. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
5. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
6. Radiation seed implant decreases risk of death over watchful waiting
7. New Heart Pump Helps Women Awaiting Transplants
8. Black Women Wait Longer for Breast Cancer Surgery
9. ER Wait Times Getting Longer
10. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
11. FDA Will Wait for Trial Results on Vytorin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... disease media outlet with a clinician-based audience, will be participating in Rare Disease ... 2017, in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to ... autism spectrum disorder (ASD) to see films in an environment that accommodates their ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
Breaking Medicine Technology: